{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:40:04Z","timestamp":1759974004929,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.medmal.2011.02.009","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T17:55:07Z","timestamp":1309370107000},"page":"499-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["R\u00e9action cutan\u00e9e apr\u00e8s une prise de pyrazinamide"],"prefix":"10.1016","volume":"41","author":[{"given":"P.","family":"Mulliez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.-L.","family":"Mbassi Fouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Roy Saint-Georges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2011.02.009_bib0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.medmal.2006.12.006","article-title":"Les effets ind\u00e9sirables des antituberculeux\u00a0: \u00e9pid\u00e9miologie, m\u00e9canismes et conduite \u00e0 tenir","volume":"37","author":"Aouam","year":"2007","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.medmal.2011.02.009_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.reval.2009.10.004","article-title":"R\u00e9actions aux antituberculeux\u00a0: prise en charge allergologique \u00e0 propos de quatre cas","volume":"50","author":"Birnbaum","year":"2010","journal-title":"Rev Fr Allergol"},{"key":"10.1016\/j.medmal.2011.02.009_bib0015","first-page":"1","article-title":"R\u00e9action inhabituelle au piril\u00e8ne","volume":"28","author":"Soyez","year":"1988","journal-title":"Rev Fr Allergol"},{"key":"10.1016\/j.medmal.2011.02.009_bib0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1378\/chest.109.3.855","article-title":"PZA hypersensitivity","volume":"109","author":"Shorr","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2011.02.009_bib0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02771765","article-title":"Place of excipients in drug-related allergy","volume":"13","author":"Barbaud","year":"1995","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.medmal.2011.02.009_bib0030","first-page":"305","article-title":"\u00c9ruption apr\u00e8s la premi\u00e8re prise d\u2019une chimioth\u00e9rapie standard antituberculeuse","volume":"15","author":"Radal","year":"1998","journal-title":"Rev Mal Pespir"},{"key":"10.1016\/j.medmal.2011.02.009_bib0035","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1034\/j.1398-9995.2002.23832_9.x","article-title":"Adverse reactions to pyrazinamide","volume":"57","author":"Ribi","year":"2002","journal-title":"Allergy"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X11000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X11000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:09:31Z","timestamp":1759972171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X11000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0399077X11000746"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2011.02.009","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9action cutan\u00e9e apr\u00e8s une prise de pyrazinamide","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2011.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}